Skip to content
healthcare.dev

JET ALERT Regular Strength

NDC 15579-201, CAFFEINE, tablet, coated, from Bell Pharmaceuticals, Inc.

Product NDC
15579-201
Status
Listed
Labeler
Bell Pharmaceuticals, Inc
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M011
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/15579-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAFFEINE100 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
15579-201-09155790201091 BOTTLE in 1 CARTON (15579-201-09) / 30 TABLET, COATED in 1 BOTTLE
15579-201-20155790201201 BOTTLE in 1 CARTON (15579-201-20) / 120 TABLET, COATED in 1 BOTTLE
15579-201-35155790201353 BLISTER PACK in 1 BOX (15579-201-35) / 10 TABLET, COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 15579-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/15579-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 15579-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.